ENOV (Enovis) E10: $-3.63 (As of Mar. 2026)


ENOV Enovis Corp ENOV
61 GF Score
Price $21.38
GF Value $49.60
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Enovis E10?

Enovis ENOV +1.09% 61 E10 is $-3.63 as of Mar. 2026. GuruFocus rates ENOV with a GF Score™ of 61/100 and a GF Value™ of $49.60 (Possible Value Trap). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Enovis's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.150. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-3.63 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Enovis was 13.30% per year. The lowest was -16.10% per year. And the median was -5.40% per year.

As of today (2026-06-24), Enovis's current stock price is $21.38. Enovis's E10 for the quarter that ended in Mar. 2026 was $-3.63. Enovis's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Enovis was 76.27. The lowest was 11.78. And the median was 26.93.


Enovis  (NYSE:ENOV) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Enovis was 76.27. The lowest was 11.78. And the median was 26.93.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Enovis E10 Related Terms


Enovis E10 Historical Data

* Premium members only.

The historical data trend for Enovis's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enovis E10 Chart

Enovis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.81 2.33 1.74 -0.82 -3.47

Enovis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.10 -1.35 -2.42 -3.47 -3.63

ENOV vs IART, AHCO, ALMR: E10 Comparison

For the Medical Devices subindustry, Enovis's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enovis Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Enovis's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Enovis's Shiller PE Ratio falls into.


ENOV
61GF Score
Enovis Corp ENOV
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enovis E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Enovis's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.15/330.2130*330.2130
=-0.150

Current CPI (Mar. 2026) = 330.2130.

Enovis Quarterly Data

per share eps CPI Adj_EPS
201606 0.960 241.018 1.315
201609 0.690 241.428 0.944
201612 0.930 241.432 1.272
201703 0.930 243.801 1.260
201706 1.290 244.955 1.739
201709 1.110 246.819 1.485
201712 0.300 246.524 0.402
201803 0.600 249.554 0.794
201806 0.930 251.989 1.219
201809 0.780 252.439 1.020
201812 1.170 251.233 1.538
201903 -1.170 254.202 -1.520
201906 -10.350 256.143 -13.343
201909 0.240 256.759 0.309
201912 -0.360 256.974 -0.463
202003 0.090 258.115 0.115
202006 -0.180 257.797 -0.231
202009 0.300 260.280 0.381
202012 0.720 260.474 0.913
202103 0.400 264.877 0.499
202106 0.560 271.696 0.681
202109 0.490 274.310 0.590
202112 -0.030 278.802 -0.036
202203 0.280 287.504 0.322
202206 1.410 296.311 1.571
202209 -1.230 296.808 -1.368
202212 -0.710 296.797 -0.790
202303 -0.430 301.836 -0.470
202306 -0.180 305.109 -0.195
202309 -0.050 307.789 -0.054
202312 0.050 306.746 0.054
202403 -1.320 312.332 -1.396
202406 -0.340 314.175 -0.357
202409 -0.580 315.301 -0.607
202412 -12.050 315.605 -12.608
202503 -0.985 319.799 -1.017
202506 -0.640 322.561 -0.655
202509 -9.990 324.800 -10.156
202512 -9.100 324.054 -9.273
202603 -0.150 330.213 -0.150

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-3.63 mean?
Enovis (ENOV) has a E10 of $-3.63 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Enovis and its competitors.
Is Enovis' E10 too high?
Enovis' current E10 is $-3.63. Overall, Enovis has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Enovis' E10 compare to IART and AHCO?
Enovis' E10 of $-3.63 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Enovis and its competitors. Enovis's current E10 is $-3.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enovis stock overvalued right now?
Based on GuruFocus' analysis, Enovis (ENOV) is currently considered Possible Value Trap. The stock's GF Value™ is $49.60, compared to a current price of $21.38 — trading 56.9% below its estimated fair value. The current E10 is $-3.63. Enovis' overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Enovis (ENOV), the current E10 is $-3.63 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Enovis (ENOV) Overvalued in 2026?

Based on GuruFocus' analysis, Enovis stock appears to be undervalued. The current stock price of $21.38 is trading 56.9% below its estimated GF Value™ of $49.60. GuruFocus considers Enovis to be Possible Value Trap.

Key valuation signals for ENOV:

  • E10: $-3.63
  • GF Value™: $49.60 vs. price of $21.38 (56.9% below fair value)
  • GF Score™: 61/100 with 6 warning signs

No single metric tells the full story. See the ENOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Enovis Business Description

Address 2711 Centerville Road, Suite 400, Wilmington, DE, USA, 19808
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
61GF Score

Get the complete analysis for ENOV

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.38
Price
$49.60
GF Value